Abstract:Constipation is often undiagnosed until the problem is well established with soiling present, which makes treatment a long and often difficult process. It is necessary to consider the wider social and family issues when managing a child with constipation and soiling. Hospital based general medical and surgical outpatient clinics may not be the ideal setting in which to deal with these problems.
“…Finally, UTI was diagnosed by urinalysis and culture in 6 studies (8,11,32,34,35,40), and in 1 study, the authors did not describe how they diagnosed UTI (28). Ten studies were conducted in a community population (10,22–27,36–38), 1 in a primary care population (9), and 12 in specialist care (8,11,28–35,39,40).…”
Section: Resultsmentioning
confidence: 99%
“…B, Proportion and 95%CI for UTIs. * These studies estimated a period prevalence of UI instead of a point prevalence for either 6 months (9), 4 months (29) or an undocumented period (31,39). C = community or primary care population; FC = functional constipation; S = specialist care population; UI = urinary incontinence; UTI = urinary tract infection.…”
Section: Resultsmentioning
confidence: 99%
“…The prevalence for UI not otherwise defined ranged between 18% and 46% (9,25,27,29,31,33,36,41), for daytime UI between 3% and 29% (9,11,24,26,28,30,41), and for nighttime UI between 13% and 47% (Fig. 2a) (9–11,28,30,32,34,35,37–39,41).…”
Section: Resultsmentioning
confidence: 99%
“…In 4 of the 22 studies measuring bladder symptoms the patients did not represented the target population exactly. These studies either included only boys (31), or excluded children belonging to our target population (ie, excluding children with earlier treatment for BBD) (22,28,29,31). In addition, not all studies included a random or consecutive sample of patients, or examined selective inclusion due to non‐response.…”
Section: Discussionmentioning
confidence: 99%
“…The characteristics of the included studies are summarized in Supplemental Digital Content 3 (http://links.lww.com/MPG/ B482). The definition of FC was reported according to the Rome III criteria for FC in 5 studies (10,11,28,36,40), to another described definition in 12 studies (9,(22)(23)(24)27,30,(32)(33)(34)(35)37,39), and to no described definition in six 6 studies (8,25,26,29,31,37). A validated or a modified version of the dysfunctional voiding symptom score (DVSS) was used in three studies (10,22,32).…”
Section: Description Of Selected Study Populationsmentioning
Objective:
The aim of the review is to perform a systematic review of the literature examining the prevalence of bladder symptoms in children with functional constipation (FC) and to compare the prevalence of those symptoms between children with and without FC.
Methods:
In this systematic review 4 databases were searched to July 2018. Studies investigating the prevalence of bladder symptoms in children aged 4 to 17 years with FC were included. There was no language restriction. Two reviewers independently extracted data and assessed study quality. Clinical heterogeneity between studies was investigated. Prevalence rates of bladder symptoms in children with FC were calculated. Relative risks were calculated to compare the prevalence of bladder symptoms between children with and without FC.
Results:
Among 23 studies of children with FC, 22 reported the prevalence bladder symptoms (12,281 children) and 7 reported the prevalence of urinary tract infections (UTIs) (687 children). The prevalence rates of single bladder symptoms, lower urinary tract symptoms (LUTS), and UTI varied between 2% to 47%, 37% to 64%, and 6% to 53%. The relative risks were 1.24 to 6.73 for 20 single bladder symptoms (12 studies) and 2.18 to 6.55 for UTI (2 studies). The 95% confidence intervals indicated significance in 14 of 20 single bladder symptoms.
Conclusions:
Bladder symptoms seem common in children with FC, but the reported prevalence varies greatly. Children with FC are more likely to have bladder symptoms than children without FC. We recommend that clinicians be aware of concomitant bladder symptoms in children presenting with FC.
“…Finally, UTI was diagnosed by urinalysis and culture in 6 studies (8,11,32,34,35,40), and in 1 study, the authors did not describe how they diagnosed UTI (28). Ten studies were conducted in a community population (10,22–27,36–38), 1 in a primary care population (9), and 12 in specialist care (8,11,28–35,39,40).…”
Section: Resultsmentioning
confidence: 99%
“…B, Proportion and 95%CI for UTIs. * These studies estimated a period prevalence of UI instead of a point prevalence for either 6 months (9), 4 months (29) or an undocumented period (31,39). C = community or primary care population; FC = functional constipation; S = specialist care population; UI = urinary incontinence; UTI = urinary tract infection.…”
Section: Resultsmentioning
confidence: 99%
“…The prevalence for UI not otherwise defined ranged between 18% and 46% (9,25,27,29,31,33,36,41), for daytime UI between 3% and 29% (9,11,24,26,28,30,41), and for nighttime UI between 13% and 47% (Fig. 2a) (9–11,28,30,32,34,35,37–39,41).…”
Section: Resultsmentioning
confidence: 99%
“…In 4 of the 22 studies measuring bladder symptoms the patients did not represented the target population exactly. These studies either included only boys (31), or excluded children belonging to our target population (ie, excluding children with earlier treatment for BBD) (22,28,29,31). In addition, not all studies included a random or consecutive sample of patients, or examined selective inclusion due to non‐response.…”
Section: Discussionmentioning
confidence: 99%
“…The characteristics of the included studies are summarized in Supplemental Digital Content 3 (http://links.lww.com/MPG/ B482). The definition of FC was reported according to the Rome III criteria for FC in 5 studies (10,11,28,36,40), to another described definition in 12 studies (9,(22)(23)(24)27,30,(32)(33)(34)(35)37,39), and to no described definition in six 6 studies (8,25,26,29,31,37). A validated or a modified version of the dysfunctional voiding symptom score (DVSS) was used in three studies (10,22,32).…”
Section: Description Of Selected Study Populationsmentioning
Objective:
The aim of the review is to perform a systematic review of the literature examining the prevalence of bladder symptoms in children with functional constipation (FC) and to compare the prevalence of those symptoms between children with and without FC.
Methods:
In this systematic review 4 databases were searched to July 2018. Studies investigating the prevalence of bladder symptoms in children aged 4 to 17 years with FC were included. There was no language restriction. Two reviewers independently extracted data and assessed study quality. Clinical heterogeneity between studies was investigated. Prevalence rates of bladder symptoms in children with FC were calculated. Relative risks were calculated to compare the prevalence of bladder symptoms between children with and without FC.
Results:
Among 23 studies of children with FC, 22 reported the prevalence bladder symptoms (12,281 children) and 7 reported the prevalence of urinary tract infections (UTIs) (687 children). The prevalence rates of single bladder symptoms, lower urinary tract symptoms (LUTS), and UTI varied between 2% to 47%, 37% to 64%, and 6% to 53%. The relative risks were 1.24 to 6.73 for 20 single bladder symptoms (12 studies) and 2.18 to 6.55 for UTI (2 studies). The 95% confidence intervals indicated significance in 14 of 20 single bladder symptoms.
Conclusions:
Bladder symptoms seem common in children with FC, but the reported prevalence varies greatly. Children with FC are more likely to have bladder symptoms than children without FC. We recommend that clinicians be aware of concomitant bladder symptoms in children presenting with FC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.